6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7406 | AKR1C3-IN-1 | NADPH | |
AKR1C3-IN-1 is a potent and selective inhibitor of AKR1C3(IC50 of 13 nM). | |||
T61790 | AKR1C3-IN-6 | ||
AKR1C3-IN-6 (Compound 1) is a powerful and specific inhibitor of AKR1C3, with IC50 values of 0.31 μM and 73.23 μM against AKR1C3 and AKR1C2, respectively. It demonstrates significant antitumor activity [1]. | |||
T78199 | S07-1066 | Others | |
S07-1066, an aldo-keto reductase 1C3 (AKR1C3) inhibitor, enhances doxorubicin (DOX) cytotoxicity by selectively inhibiting AKR1C3-mediated reduction of DOX and reversing DOX resistance in cells with elevated AKR1C3 expre... | |||
T79433 | AKR1C3-IN-10 | ||
AKR1C3-IN-10 (compound 5r), a selective inhibitor of AKR1C3 with an IC50 of 51 nM, demonstrates efficacy in a prostate cancer xenograft model [1]. | |||
T61511 | S07-2005 (racemic) | ||
S07-2005 racemic is a chemically potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3), with an IC50 value of 0.13 μM and 0.75 μM for AKR1C3 and AKR1C4, respectively. Due to its inhibitory properties, it exh... | |||
T61485 | S07-2010 | ||
S07-2010 is a potent pan-AKR1C inhibitor, effectively inhibiting AKR1C3, AKR1C4, AKR1C1, and AKR1C2 with IC50 values of 0.19, 0.36, 0.47, and 0.73 μM, respectively. This compound induces apoptosis in A549/DDP cells and e... |